No connection

Search Results

OGI

BEARISH
$1.52 Live
Organigram Global Inc. · NASDAQ
$1.0 52W Range $2.24
Overview AI Snowflake Price Valuation Profitability Growth Health Statements Peers Insiders

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 16, 2026
Market cap
$209.6M
P/E
13.82
ROE
4.6%
Profit margin
6.5%
Debt/Equity
0.02
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
OGI exhibits severe financial fragility, highlighted by a weak Piotroski F-Score of 2/9 and a negative operating margin of -5.38%. While the stock appears undervalued relative to its Graham Number ($2.21) and Price-to-Book ratio (0.77), the intrinsic value is significantly lower at $0.77. Strong top-line revenue growth of 48.7% is currently offset by a poor earnings track record and a concerning spike in Forward P/E (from 13.82 to 84.44), suggesting a projected collapse in earnings. The company is essentially a speculative play on revenue growth that has yet to prove operational sustainability.

Key Strengths

Strong YoY revenue growth of 48.70%
Very low leverage with a Debt/Equity ratio of 0.02
Trading below book value (P/B 0.77)
Healthy Current Ratio of 2.73 providing short-term liquidity
Low Price-to-Sales ratio (0.75) relative to sector

Key Risks

Critical financial health weakness (Piotroski F-Score 2/9)
Negative operating margin (-5.38%) indicating core business losses
Severe earnings volatility with an average surprise of -949.02% over the last 4 quarters
Significant deterioration in forward earnings expectations (Forward P/E 84.44)
Poor liquidity quality as evidenced by a low Quick Ratio (0.62) compared to Current Ratio
AI Fair Value Estimate
Based on comprehensive analysis
$1.15
-24.3% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
27
Weak
Value
55
Future
40
Past
20
Health
20
Dividend
0
AI Verdict
Speculative/High Risk
Key drivers: Piotroski F-Score, Forward P/E expansion, Operating Margin, Revenue Growth
Confidence
90%
Value
55/100

Graham Number $2.21 vs Current Price $1.52

Positives
  • P/B below 1.0
  • P/S below 1.0
  • Current price below Graham Number
Watchpoints
  • Intrinsic value estimate is significantly lower than current price
Future
40/100

Revenue growth is strong, but profitability is not scaling

Positives
  • High YoY revenue growth (48.7%)
Watchpoints
  • Forward P/E suggests a massive drop in expected earnings
  • Inconsistent earnings beats
Past
20/100

Long-term trend is heavily bearish despite short-term bounces

Positives
  • 1-year price recovery of 46.1%
Watchpoints
  • 5-year price collapse of -84.9%
  • Chronic history of missing earnings estimates
Health
20/100

Piotroski score indicates fundamental weakness

Positives
  • Negligible debt
Watchpoints
  • Piotroski F-Score 2/9
  • Negative operating margin
  • Low Quick Ratio
Dividend
0/100

Dividend Strength 0/100

Positives
No standout positives identified.
Watchpoints
  • No dividend payments

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$1.52

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for OGI and closest competitors.

Updated 2026-04-15
OGI
Organigram Global Inc.
Primary
5Y
-84.9%
3Y
-32.0%
1Y
+46.1%
6M
-22.4%
1M
+7.0%
1W
+9.3%
PRQ
ProQR Therapeutics N.V.
Peer
5Y
-66.2%
3Y
-8.3%
1Y
+74.6%
6M
-28.4%
1M
+15.7%
1W
+7.6%
MEN
Jyong Biotech Ltd.
Peer
5Y
-72.4%
3Y
-72.4%
1Y
-72.4%
6M
-95.0%
1M
+40.9%
1W
+13.0%
OAB
OmniAb, Inc.
Peer
5Y
-84.8%
3Y
-59.8%
1Y
-21.7%
6M
-13.4%
1M
-19.1%
1W
-2.6%
HIT
High Tide Inc.
Peer
5Y
-71.8%
3Y
+84.9%
1Y
+18.3%
6M
-32.1%
1M
-5.7%
1W
+0.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
13.82
Forward P/E
84.44
PEG Ratio
N/A
P/B Ratio
0.77
P/S Ratio
0.75
EV/Revenue
0.93
EV/EBITDA
47.95
Market Cap
$209.6M

Profitability

Profit margins and return metrics

Profit Margin 6.49%
Operating Margin -5.38%
Gross Margin 35.61%
ROE 4.64%
ROA -1.47%

Growth

Revenue and earnings growth rates

Revenue Growth +48.7%
Earnings Growth N/A
Q/Q Revenue Growth +48.7%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.02
Low debt
Current Ratio
2.73
Strong
Quick Ratio
0.62
Poor
Cash/Share
$0.06

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.1B
Gross Margin
36.7%
Op. Margin
-5.4%
Net Margin
31.4%
Total Assets
$0.5B
Liabilities
$0.2B
Equity
$0.4B
Debt/Equity
0.44x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
113%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-13
$N/A
2026-02-10
$-0.01
-79.4% surprise
2025-12-16
$-0.2
-2827.1% surprise
2025-08-13
$-0.01
+59.5% surprise

Healthcare Sector Comparison

Comparing OGI against 421 companies in the Healthcare sector (25 bullish, 134 neutral, 262 bearish)
P/E Ratio
13.82
This Stock
vs
89.02
Sector Avg
-84.5% (Discount)
Return on Equity (ROE)
4.64%
This Stock
vs
-100.15%
Sector Avg
-104.6% (Below Avg)
Profit Margin
6.49%
This Stock
vs
-13.63%
Sector Avg
-147.6% (Weaker)
Debt to Equity
0.02
This Stock
vs
3.22
Sector Avg
-99.4% (Less Debt)
Revenue Growth
48.7%
This Stock
vs
121.05%
Sector Avg
-59.8% (Slower)
Current Ratio
2.73
This Stock
vs
4.55
Sector Avg
-40.0% (Weaker)

Similar Companies

Peer comparison within the same industry

OGI Organigram Global Inc.
BEARISH
Mkt Cap
$210M
P/E
13.8
ROE
4.6%
Price
$1.52
PRQR ProQR Therapeutics N.V.
BEARISH
Mkt Cap
$210M
P/E
-
ROE
-61.2%
Price
$1.99
 Compare with OGI
MENS Jyong Biotech Ltd.
BEARISH
Mkt Cap
$212M
P/E
-
ROE
-%
Price
$2.79
 Compare with OGI
OABI OmniAb, Inc.
BEARISH
Mkt Cap
$214M
P/E
-
ROE
-23.4%
Price
$1.48
 Compare with OGI
HITI High Tide Inc.
BEARISH
Mkt Cap
$205M
P/E
-
ROE
-39.7%
Price
$2.33
 Compare with OGI

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Machum (Donald Geoffrey)
Director of Issuer
Stock Award
2026-03-26
100 shares
Machum (Donald Geoffrey)
Director of Issuer
Disposi...
2026-03-26
100 shares · $134
Machum (Donald Geoffrey)
Director of Issuer
Stock Award
2026-03-26
400 shares
Machum (Donald Geoffrey)
Director of Issuer
Disposi...
2026-03-26
400 shares · $546
Machum (Donald Geoffrey)
Director of Issuer
Stock Award
2026-03-26
400 shares
Machum (Donald Geoffrey)
Director of Issuer
Disposi...
2026-03-26
400 shares · $544
Machum (Donald Geoffrey)
Director of Issuer
Stock Award
2026-03-26
200 shares
Machum (Donald Geoffrey)
Director of Issuer
Disposi...
2026-03-26
200 shares · $273
Machum (Donald Geoffrey)
Director of Issuer
Stock Award
2026-03-26
1,600 shares
Machum (Donald Geoffrey)
Director of Issuer
Disposi...
2026-03-26
1,600 shares · $2,187
Machum (Donald Geoffrey)
Director of Issuer
Stock Award
2026-03-26
1,100 shares
Machum (Donald Geoffrey)
Director of Issuer
Disposi...
2026-03-26
1,100 shares · $1,508
Machum (Donald Geoffrey)
Director of Issuer
Stock Award
2026-03-26
2,600 shares
Machum (Donald Geoffrey)
Director of Issuer
Disposi...
2026-03-26
2,600 shares · $3,575
Machum (Donald Geoffrey)
Director of Issuer
Stock Award
2026-03-26
3,700 shares
Insider transactions can signal confidence or concerns about company prospects

Past News Coverage

Recent headlines mentioning OGI from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile